Food and Drug Administration / European Medicines Agency orphan-product designation and grant workshop

• Date:
  Friday, 12 October 2012, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The European Medicines Agency (EMA) cooperates with many of the world's largest regulatory bodies outside the European Union including the Food and Drug Administration (FDA) in the United States. As part of this cooperation, this one-day workshop is designed to provide valuable information about the EMA and FDA orphan-medicine designation frameworks and related grant programmes. It is being held in partnership with EURORDIS, Genetic Alliance and the National Organization for Rare Disorders (NORD). No registration fee.